Dalekos G et al. Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. (Abstract GS-02)
Amsterdamse analyse toont dat COVID-19-gerelateerd ARDS heterogeen is
okt 2021 | Pneumonie, Virale infecties